[1]
“Bridging the Gap in Breast Cancer Care for LMICs: Cost-effective PCR-based testing as an alternative to the ctDNA sequencing method to detect ESR1 mutation”, MJBR, vol. 1, no. 2, pp. 84–91, Sep. 2026, doi: 10.64913/mmrmjbr.v1i2.57.